Brief: Scope Fluidics Plans To Complete Clinical Certification Tests For PCR|ONE Panel In Q1 2021
04/12/2020 07:48
Dec 4 (Reuters) - Scope Fluidics SA SCPP.WA :
* PLANS TO COMPLETE CLINICAL CERTIFICATION TESTS FOR PCR|ONE
SARS-COV-2 PANEL, BOTH CE-IVD AND FDA EUA IN Q1 2021
Source text for Eikon: ID:nEM7FlXhta
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys